4.3.1.6. Tocilizumab
Tocilizumab is an immunosuppressive drug.  This is a recombinant humanized monoclonal immunoglobulin antibody against human IL-6 . It acts as an antagonist towards IL-6activity which is an essential member of the human immune response . Patients with COVID-19 displayed high levels of cytokines (cytokine storm) which included IL-6. This could be attributed to the severity of the disease as well as the inflammation seen . Therefore, by targeting IL-6 with Tocilizumab this symptom could be overcome and could aid in inhibiting the progress of the disease. This is generally the suggested treatment when there are extensive lung lesions observed in the patient .